Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Lilly Declares Fourth-Quarter 2018 Dividend

Eli Lilly and Company
Posted on: 15 Oct 18
Lilly Declares Fourth-Quarter 2018 Dividend

PR Newswire

INDIANAPOLIS, Oct. 15, 2018

INDIANAPOLIS, Oct. 15, 2018 /PRNewswire/ -- The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the fourth quarter of 2018 of $0.5625 per share on outstanding common stock.

The dividend is payable December 10, 2018, to shareholders of record at the close of business on November 15, 2018.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY   

Refer to:  Mark Taylor; mark.taylor@lilly.com; (317) 276-5795 (Media)
                Kevin Hern; hern_kevin_r@lilly.com; (317) 277-1838 (Investors)            

View original content to download multimedia:http://www.prnewswire.com/news-releases/lilly-declares-fourth-quarter-2018-dividend-300731162.html

SOURCE Eli Lilly and Company

PR Newswire
www.prnewswire.com

Last updated on: 15/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.